Cargando…

Vaccine strategies to reduce the burden of pneumococcal disease in HIV-infected adults in Africa.

INTRODUCTION: Streptococcus pneumoniae is the leading cause of invasive bacterial disease, globally. Despite antiretroviral therapy, adults infected with human immunodeficiency virus (HIV) are also at high risk of pneumococcal carriage and disease. Pneumococcal conjugate vaccines (PCVs) provide effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thindwa, Deus, Pinsent, Amy, Ojal, John, Gallagher, Katherine E, French, Neil, Flasche, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315211/ https://www.ncbi.nlm.nih.gov/pubmed/33269987 http://dx.doi.org/10.1080/14760584.2020.1843435

Ejemplares similares

Estimating the contribution of HIV-infected adults to household pneumococcal transmission in South Africa, 2016–2018: A hidden Markov modelling study
por: Thindwa, Deus, et al.
Publicado: (2021)

Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi
por: Thindwa, Deus, et al.
Publicado: (2022)

Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
por: Flasche, Stefan, et al.
Publicado: (2020)

Social mixing patterns relevant to infectious diseases spread by close contact in urban Blantyre, Malawi
por: Thindwa, Deus, et al.
Publicado: (2022)

Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality
por: Thindwa, Deus, et al.
Publicado: (2020)

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study
por: Thindwa, Deus, et al.
Publicado: (2023)

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
por: Ojal, John, et al.
Publicado: (2019)

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya
por: Flasche, Stefan, et al.
Publicado: (2017)

Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data
por: Ojal, John, et al.
Publicado: (2017)

The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries
por: Flasche, Stefan, et al.
Publicado: (2015)

The Serotype Distribution among Healthy Carriers before Vaccination Is Essential for Predicting the Impact of Pneumococcal Conjugate Vaccine on Invasive Disease
por: Flasche, Stefan, et al.
Publicado: (2015)

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review
por: Kalata, Newton L., et al.
Publicado: (2019)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation
por: Wolf, Asia-Sophia, et al.
Publicado: (2022)

Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination
por: Masala, G. L., et al.
Publicado: (2017)

Pneumococcal vaccine schedules (PVS) study: a cluster-randomised, non-inferiority trial of an alternative versus standard schedule for pneumococcal conjugate vaccination—statistical analysis plan
por: Mackenzie, Grant A., et al.
Publicado: (2022)

Effect and cost-effectiveness of pneumococcal conjugate vaccination: a global modelling analysis
por: Chen, Cynthia, et al.
Publicado: (2018)

The impact of introduction of the 10-valent pneumococcal conjugate vaccine on pneumococcal carriage in Nigeria
por: Adamu, Aishatu L., et al.
Publicado: (2023)

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine
por: Moïsi, Jennifer C., et al.
Publicado: (2017)

Pneumococcal vaccination and childhood pneumonia in South Africa
por: Mulholland, Kim, et al.
Publicado: (2015)

Evaluation of the effect of reduced-dose pneumococcal conjugate vaccine schedules on vaccine serotype carriage in children and their caretakers in a naïve population in Vietnam: Protocol for a cluster randomized non-inferiority trial
por: Yoshida, Lay-Myint, et al.
Publicado: (2023)

Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam
por: Le Polain De Waroux, Olivier, et al.
Publicado: (2018)

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage
por: Ojal, John, et al.
Publicado: (2017)

Theory and strategy for Pneumococcal vaccines in the elderly
por: Namkoong, Ho, et al.
Publicado: (2015)

Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020)

Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study
por: Swarthout, Todd D, et al.
Publicado: (2022)

Effect of Pneumococcal Conjugate Vaccination on Serotype-Specific Carriage and Invasive Disease in England: A Cross-Sectional Study
por: Flasche, Stefan, et al.
Publicado: (2011)

The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program
por: Ho, Yi-Chien, et al.
Publicado: (2015)

Burden of invasive pneumococcal disease in children in Casablanca, Morocco four years after the introduction of pneumococcal vaccination
por: Chikhaoui, Amar, et al.
Publicado: (2022)

Pneumococcal Conjugate Vaccine Given Shortly After Birth Stimulates Effective Antibody Concentrations and Primes Immunological Memory for Sustained Infant Protection
por: Scott, J. Anthony G., et al.
Publicado: (2011)

Effectiveness of 7-Valent Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease in HIV-Infected and -Uninfected Children in South Africa: A Matched Case-Control Study
por: Cohen, Cheryl, et al.
Publicado: (2014)

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination
por: Bhorat, As’ad E., et al.
Publicado: (2015)

Clinical burden of pneumococcal septicaemia
por: Maimaiti, Namaitijiang, et al.
Publicado: (2014)

Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Pneumococcal carriage in households in Karonga District, Malawi, before and after introduction of 13-valent pneumococcal conjugate vaccination
por: Heinsbroek, Ellen, et al.
Publicado: (2018)

Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial
por: Sadlier, C., et al.
Publicado: (2016)

Infant contact in day-care centres in Vietnam: A cross-sectional study to understand infant infection risk
por: Toizumi, Michiko, et al.
Publicado: (2019)

The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study
por: Siemieniuk, Reed AC, et al.
Publicado: (2011)

Correction to: Estimates of the Health and Economic Burden of Pneumococcal Infections Attributable to the 15-Valent Pneumococcal Conjugate Vaccine Serotypes in the USA
por: Owusu-Edusei, Kwame, et al.
Publicado: (2022)

Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea
por: Heo, Jung Yeon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nmev256a8ss4p792ofrpcj9kki